Company Long-Term Loans and Borrowings: Aclaris (ACRS)
Aclaris Therapeutics is currently focusing its operations on clinical trials, where customer base growth is constrained by FDA rulings. Meanwhile, the patent licensing strategy minimizes risks, establishing a foundation for a stable cash flow, which amounts to 0.00. This price chart reflects the asset's dynamics. Business development relies on scientific alliances with immunology centers to create therapies for skin pathologies.
Aclaris (ACRS) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Aclaris Therapeutics|ACRS - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Aclaris Therapeutics, Inc|ACRS - Company Debts|Debt to Book Value Aclaris Therapeutics|ACRS - Company Long-Term Debt|Company Current Liabilities Aclaris Therapeutics|Quick Ratio aclaristx.com
- earnings and multiples data:
Analysis of all company metrics:ACRS - aclaristx.com
Aclaris Therapeutics (ACRS) invests in the development of immunological drugs featuring long therapy cycles and patent protection. The company's long-term debt time series captures obligations with maturities exceeding one year, reflecting the volume of borrowed capital used to fund R&D. Growth in this metric indicates the scaling of innovation, yet increases financial risks amid rising interest rates. The stability of this metric confirms the business model's resilience to debt service costs.
Competitors of Aclaris Therapeutics (ACRS)
Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Long-Term Indebtedness|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Long-Term Debt|Zenas Biopharma, Inc. - Company Long-Term Debts|IMNM - Company Long-Term Debts|GOSS: Company Long-Term Debts|Company Long-Term Liabilities kalvista.com|Company Long-Term Debt Septerna|Company Long-Term Debt PVLA|Company Long-Term Debts SVRA|Company Long-Term Debts Rigel Corp (RIGL)|Company Long-Term Debt AnaptysBio, Inc. ANAB|Company Long-Term Loans and Borrowings ATXS|enGene - Company Long-Term Debts|Long-Term Debt Volume rapt.com RAPT|aerovatetx.com (JBIO) - Company Long-Term Debt|KYTX - Long-Term Debt Volume|Company Long-Term Liabilities TLSA|CABA: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities VTYX (Ventyx Biosciences, Inc.)|Amount of Long-Term Liabilities THTX|Company Long-Term Debts AVTX (Avalo Therapeutics Inc.)|Company Long-Term Loans and Borrowings ELDN|Agenus - Company Long-Term Debts|Long-Term Debt climbbio.com|Zura Bio Limited (ZURA) - Company Long-Term Debt|aTyr Pharma Inc - Company Long-Term Loans and Borrowings|ADAG (Adagene Inc) - Company Long-Term Debts|Company Long-Term Debts Ikena Oncology, Inc.|Company Long-Term Debt Shattuck Labs, Inc. (STTK)|EQ: Long-Term Liabilities|Company Long-Term Debts CNTB (Connect Biopharma Holdings Limited)|Immunic Therapeutics (IMUX) - Long-Term Debt|ATRA: Company Long-Term Liabilities|IFRX - Company Long-Term Debts|XFOR (X4 Pharmaceuticals) - Company Long-Term Liabilities|ACET: Amount of Long-Term Liabilities|CELU (Celularity Inc) - Company Long-Term Debts|INmune Bio Inc (INMB) - Long-Term Debt Volume|Company Long-Term Debts BRNS|Company Long-Term Liabilities Kezar Life Sciences Inc KZR|Company Long-Term Debt SAB Biotherapeutics SABS|Long-Term Debt Volume akaritx.com (AKTX)|Enlivex Therapeutics, Ltd. - Company Long-Term Debts|QTTB - Company Long-Term Debts|GOVX: Company Long-Term Debts|Company Long-Term Liabilities Edesa Biotech Corp|Company Long-Term Debt iBio, Inc.|CARM: Company Long-Term Loans and Borrowings|Company Long-Term Debt XTL Biopharmaceuticals Ltd. (XTLB)|Long-Term Debt Volume boltbio.com|Company Long-Term Debt HCW Biologics HCWB|APVO (Aptevo Therapeutics, Inc.) - Long-Term Liabilities|AIM ImmunoTech - Company Long-Term Debts|Company Long-Term Loans and Borrowings ADTX (Aditxt)|GRI: Company Long-Term Debts|XORTX Therapeutics Inc (XRTX) - Company Long-Term Debts|Company Long-Term Debt ReShape Lifesciences|REVB: Company Long-Term Loans and Borrowings|Company Long-Term Debt Indaptus Therapeutics (INDP)|Company Long-Term Liabilities scinai.com SCNI|Company Long-Term Debts CALI (CalciMedica)|Company Long-Term Debts Affimed NV AFMD|ALLK: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings HOOK (HOOKIPA Pharma Inc.)|IGMS: Company Long-Term Debts|ITOS - Long-Term Debt Volume|Company Long-Term Debt Ocean Biomedical|Company Long-Term Liabilities TC BioPharm (Holdings) Plc (TCBP)|Company Long-Term Debt Third Harmonic Bio, Inc (THRD)